Collaboration
RXi Pharmaceuticals and Karolinska Institutet Enter into Collaboration to Develop sd-rxRNA Compounds to Improve Functionality and Persistence of T Cells and NK Cells
RXi Pharmaceuticals
PR-M09-18-NI-049Sep 18, 2018
Trial Results
RXi Pharmaceuticals Announces Positive Results from Phase 2 Trial with Samcyprone™ for the Treatment of Common Warts
RXi Pharmaceuticals
PR-M05-18-NI-089May 23, 2018